Dairy and infant formula business a2 Milk Company Ltd (Australia) (ASX: A2M) has produced a stellar first-half earnings report today. Not only did it announce a massive 86% increase in revenue over the prior corresponding period (pcp), it also increased its full-year earnings guidance yet again.

The company’s New Zealand-listed shares soared more than 27% early in today’s session, implying a strong day for Australian shareholders.

The Results

The a2 Milk Company was one of the top-performing shares on the ASX in the latter half of 2015 as a result of its booming sales of infant formula at a time when the so-called “white gold” was experiencing a heavily-publicised shortage.

The shares have continued to surge higher, spurred on by a series of updates to earnings guidance that came late in the year leading into Christmas. Most recently, it guided for full-year revenue to be between $300 million and $315 million, while earnings before interest, tax, depreciation and amortisation (EBITDA) are expected to be between $33 million and $37 million.

The company only reported its results for the first six-months of the year today, but they were certainly impressive. Here were some of the results:

  • Total revenue of $139.1 million, up 86% on the pcp
  • Sales of its a2 Platinum infant formula product soared 340% to $73.9 million (Notably, the company had already advised that sales of this product had reached $38 million in the four months ended 31 October, 2015. That suggests it made another $35.9 million in the final two months of the half-year)
  • Group EBITDA up 472% to $18.7 million
  • Net profit after tax (NPAT) of $10.1 million, up from $0.1 million in the pcp

Given that the EBITDA result was already more than half of a2 Milk’s upper guidance for full-year EBITDA ($37 million), the company has, understandably, increased its full-year guidance yet again.

It’s now telling investors to expect revenue in the range of $335 million to $350 million and group EBITDA between $45 million and $49 million. The mid-point of the new EBITDA guidance is an astonishing 34% improvement on the guidance provided as recently as December.

What happens now?

The company’s infant formula is clearly a huge hit with customers, and is driving much of the company’s growth. What could help drive earnings even higher is growth in its direct sales into China, which is something that a2’s rival Bellamy’s Australia Ltd (ASX: BAL) is also capitalising on. Meanwhile, an increase in its production schedule with the NZ-based Synlait Milk Limited should also help it to meet the growing levels of demand.

What’s more, the company is also developing a growth strategy into the United Kingdom and United States markets, while it has also identified a “significant growth opportunity” in its a2 Milk branded milk powder, which was launched in limited release from June 2015.

It is clear this was a very strong result from a2 Milk, and it certainly goes a way towards justifying the company’s soaring share price. Although the shares aren’t cheap, per se, they could be well worth holding onto for the long-run.

Our BEST stock idea for 2016 - FREE!

Our top analysts have recently selected their TOP stock idea for 2016, and with share prices falling, it could be the BEST time to buy! This relatively unknown technology share is growing rapidly and offers a fat, fully franked dividend! Best of all: their top stock idea for 2016 is yours FREE! Just click here, enter your email address and claim your free report - no payment or credit card required!

HOT OFF THE PRESSES: Motley Fool’s #1 Dividend Pick for 2017!

With its shares up 155% in just the last five years, this ‘under the radar’ consumer favourite is both a hot growth stock AND our expert’s #1 dividend pick for 2017. Now we’re pulling back the curtain for you... And all you have to do to discover the name, code and a full analysis is enter your email below!

Simply enter your email now to receive your copy of our brand-new FREE report, “The Motley Fool’s Top Dividend Stock for 2017.”

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our https://www.fool.com.au/financial-services-guide">Financial Services Guide (FSG) for more information.

Motley Fool contributor Ryan Newman owns shares of Bellamy's Australia. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. You can follow Ryan on Twitter @ASXvalueinvest.

The Motley Fool Australia owns shares of Bellamy's Australia. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.